187 related articles for article (PubMed ID: 29408906)
21. Clinical Effects and Safety of Tongxieyaofang on Diarrhea Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized Trails.
Zhou Y; Han S; He Y
Evid Based Complement Alternat Med; 2019; 2019():4893876. PubMed ID: 30723513
[No Abstract] [Full Text] [Related]
22. Effectiveness of Tong-Xie-Yao-Fang combined with Si-Ni-San for irritable bowel syndrome: A protocol for systematic review and meta-analysis.
Jiang J; Chen Y; Hu Z; Li H; Ye J; Yu Z; Tang H
Medicine (Baltimore); 2021 Mar; 100(11):e25198. PubMed ID: 33726014
[TBL] [Abstract][Full Text] [Related]
23. Herbal medicines for treatment of irritable bowel syndrome.
Liu JP; Yang M; Liu YX; Wei M; Grimsgaard S
Cochrane Database Syst Rev; 2006 Jan; (1):CD004116. PubMed ID: 16437473
[TBL] [Abstract][Full Text] [Related]
24. External therapy of traditional Chinese medicine for treating irritable bowel syndrome with diarrhea: A systematic review and meta-analysis.
Wei X; Wen Y; Wei Y; Liang X; Ma X; Zhang B; Tang X
Front Med (Lausanne); 2022; 9():940328. PubMed ID: 36017012
[TBL] [Abstract][Full Text] [Related]
25. Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome.
Chen M; Tang TC; Wang Y; Shui J; Xiao XH; Lan X; Yu P; Zhang C; Wang SH; Yao J; Zheng H; Huang DQ
Aliment Pharmacol Ther; 2018 Jul; 48(2):160-168. PubMed ID: 29856472
[TBL] [Abstract][Full Text] [Related]
26. Probiotics therapy for adults with diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 RCTs.
Wang Y; Chen N; Niu F; Li Y; Guo K; Shang X; E F; Yang C; Yang K; Li X
Int J Colorectal Dis; 2022 Nov; 37(11):2263-2276. PubMed ID: 36251040
[TBL] [Abstract][Full Text] [Related]
27. Xiaoyao-san, a traditional Chinese herbal formula, for the treatment of irritable bowel syndrome: A protocol for a systematic review and meta-analysis.
Lee J; Sung WS; Kim EJ; Kim YW
Medicine (Baltimore); 2021 Mar; 100(10):e24019. PubMed ID: 33725813
[TBL] [Abstract][Full Text] [Related]
28. Moxibustion for diarrhea-predominant irritable bowel syndrome: A protocol for systematic review and network meta-analysis.
Dong T; Li X; Ma X; Xue X; Hou Y; Liu Y; Yang J
Medicine (Baltimore); 2021 Dec; 100(51):e28373. PubMed ID: 34941160
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy and mechanism of acupuncture combined with
Wang SS; Wang XR; Yang RY; Xu Y; Li MY
Zhongguo Zhen Jiu; 2020 Jun; 40(6):605-9. PubMed ID: 32538010
[TBL] [Abstract][Full Text] [Related]
30. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
31. Acupuncture for treatment of irritable bowel syndrome.
Manheimer E; Cheng K; Wieland LS; Min LS; Shen X; Berman BM; Lao L
Cochrane Database Syst Rev; 2012 May; 5(5):CD005111. PubMed ID: 22592702
[TBL] [Abstract][Full Text] [Related]
32. Acupuncture for Adults with Diarrhea-Predominant Irritable Bowel Syndrome or Functional Diarrhea: A Systematic Review and Meta-Analysis.
Guo J; Xing X; Wu J; Zhang H; Yun Y; Qin Z; He Q
Neural Plast; 2020; 2020():8892184. PubMed ID: 33299403
[No Abstract] [Full Text] [Related]
33. Chinese herbal formula siwutang for treating primary dysmenorrhea: A systematic review and meta-analysis of randomized controlled trials.
Li G; Liu A; Lin M; Liao S; Wen Z
Maturitas; 2020 Aug; 138():26-35. PubMed ID: 32631585
[TBL] [Abstract][Full Text] [Related]
34. To assess the effective and safety of compound glutamine entersoluble capsules in irritable bowel syndrome: A protocol for systematic review and meta-analysis.
Zhang Y; Liu R; Wang J; Yan S; Guo Z
Medicine (Baltimore); 2021 Mar; 100(10):e25098. PubMed ID: 33725903
[TBL] [Abstract][Full Text] [Related]
35. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
Tang XD; Zhang SS; Hou XH; Li ZH; Chen SN; Feng PM; Yang XN; Li HZ; Wu JQ; Xia PJ; Yang XJ; Zhou HJ; Wang HY; Ai YW; Li K
Chin J Integr Med; 2019 Dec; 25(12):887-894. PubMed ID: 31292845
[TBL] [Abstract][Full Text] [Related]
36. The Efficacy and Safety of Chinese Herbal Medicine in the Treatment of Knee Osteoarthritis: An Updated Systematic Review and Meta-Analysis of 56 Randomized Controlled Trials.
Lin Z; Zheng J; Chen M; Chen J; Lin J
Oxid Med Cell Longev; 2022; 2022():6887988. PubMed ID: 35035664
[TBL] [Abstract][Full Text] [Related]
37. Adverse events in trials of licensed drugs for irritable bowel syndrome with constipation or diarrhea: Systematic review and meta-analysis.
Barberio B; Savarino EV; Black CJ; Ford AC
Neurogastroenterol Motil; 2022 Jun; 34(6):e14279. PubMed ID: 34672052
[TBL] [Abstract][Full Text] [Related]
38. [A meta-analysis of probiotics for the treatment of irritable bowel syndrome].
Hu Y; Tao L; Lyu B
Zhonghua Nei Ke Za Zhi; 2015 May; 54(5):445-51. PubMed ID: 26080826
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of opioid receptor modulators in patients with irritable bowel syndrome: A systematic review and meta-analysis.
Li X; Li B; Zhang J; Chen T; Wu H; Shi X; Ma J; Qin J; Tang X; Wang F
Medicine (Baltimore); 2021 Jan; 100(4):e24361. PubMed ID: 33530231
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological treatments of Chinese herbal medicine for irritable bowel syndrome in adults: A network meta-analysis of randomized controlled trials.
Wu YB; Dai YK; Zhang L; Pan HG; Chen WJ; Li RL; Hu L
PLoS One; 2021; 16(8):e0255665. PubMed ID: 34358263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
